Skip to main content

Table 1 A description of the 18 patient subjects completing the study

From: Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine

  Patients (n = 18)
Gender (M:F) 8:10
Age at recruitment (years) 17.7 (1.9)
Age of onset (years) 13.9 (3.0)
Polarity of index episode (%) d, D, m, M 61, 22, 0, 17
Duration of illness (years) 3.4 (2.7)
Most recent mood episode (%) D, m, M 33, 45, 22
Bipolar Diagnosis (%)  
   BPI 22
   BPII 11
   BPNOS 67
Lifetime Psychotic Features (%) 61
Hospitalization Ever (%) 44
Clinical Course (%)  
   Episodic 11
   Non-Episodic 89
Comorbid Disorders (%)  
   Anxiety 33
   ADHD 22
   Sleep 17
   None 22
Mean quetiapine dose over the study (SD) 340.9 mg (276.5)
Mean quetiapine dose at study end (SD) 294.6 mg (267.3)
  1. d refers to minor depression, D to major depression, m to hypomania and M to either Manic or mixed episode